Ilwha NA

Ilwha North America is the regional division of Ilhwa Co., Ltd., a South Korean leader in ginseng science and pharmaceutical development. The company is globally recognized for its proprietary enzyme fermentation technology, which significantly enhances the bioavailability of ginsenosides by converting them into the highly absorbable metabolite Compound K (IH-901). Their primary product line, GinST 15, utilizes this technology to provide high-absorption ginseng extracts for various health applications. Beyond its focus on nutraceuticals, the company leverages its research into natural compounds to address indications such as fatigue, stress, and immune system support. Ilwha North America serves as the primary distribution and marketing hub for these advanced botanical products in the Western market.